The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...
The firm is aiming to break even on its cash flow by 2027 by narrowing its focus on its sarcoma treatments and pipeline candidates with greatest potential.
Mother-to-child HBV transmission was effectively prevented by earlier initiation of TDF prophylaxis in pregnancy combined with HBV vaccination at birth for infants.